A Puente, J I Fortea, C Del Pozo, M Serrano, M Alonso-Peña, A Giráldez, L Tellez, J Martinez, M Magaz, L Ibañez, J Garcia, E Llop, C Alvarez-Navascues, M Romero, E Rodriguez, M T Arias Loste, A Antón, V Echavarria, C López, A Albillos, V Hernández-Gea, J C Garcia-Pagán, R Bañares, J Crespo
BACKGROUND AND AIMS: Oxaliplatin (OX) has been described as a potential etiologic agent for porto-sinusoidal vascular disorder (PSVD). Our aim was to describe the natural history of PSVD due to OX in colon cancer (CRC) and identify risk factors for its development. METHODS: We made a multicenter retrospective case-control (ratio 1:3) study with patients diagnosed of PSVD-OX. Baseline data, end of treatment, years of follow-up and diagnosis of PSVD were collected and compared to controls (without PSVD)...
May 7, 2024: Digestive and Liver Disease